Schizophrenia Trial, Recruiting NCT07360665 Sponsor: University of Trás-os-Montes and Alto Douro Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT07360665
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You have been diagnosed with psychosis by a doctor
  • You are currently receiving your antipsychotic medication as a long-acting injection (a shot given every few weeks instead of daily pills)
  • You are currently being seen and monitored at the Antipsychotic Clinic of ULSTMAD
  • Your psychiatrist has confirmed in writing that you are able to understand and take part in the study
  • You are able to give your written agreement to take part, either yourself or through someone who legally represents you
  • (For the exercise group only) You live close enough to the exercise sessions to be able to attend them in person

Who may not be able to join:

  • You miss more than 15% of the supervised exercise sessions (this applies to the exercise group only)
  • You are unable or unwilling to attend all four of the main check-in or assessment appointments during the study
  • You decide at any point that you no longer wish to take part or are unable to give your agreement to join
  • You are not currently receiving your antipsychotic medication as a long-acting injection
  • You are not a patient at the Antipsychotic Clinic of ULSTMAD

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Trás-os-Montes and Alto Douro
Registry
ClinicalTrials.gov
Start date
1 January 2026
Est. completion
31 October 2026

Where this trial is recruiting

🇵🇹 Portugal

Primary endpoints

Body mass/weight; Body mass index (BMI); Body fat percentage; Lean body mass; Sit-to-Stand Test _ 30s; Handgrip Test; European Health Interview Survey - Quality of Life 8-item Index (EUROHIS-QOL-8); Patient Health Questionnaire-9 - PHQ-9; Positive and Negative Affect Scale (PANAS); Serum Brain-Derived Neurotrophic Factor (BDNF) levels; Serum lipid profile; Glycemic and metabolic markers; Serum Serotonin levels; Serum Dopamine levels

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov